Study the natural history of newborn screening disorders to improve treatment, genetic understanding, and outcomes for infants.
Funder: National Institutes of Health
Due Dates: February 5, 2027 (New) | March 5, 2027 (Renewal/resubmission/revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/resubmission/revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/resubmission/revision) | January 7, 2028 (Closing date)
Funding Amounts: No budget cap; requests must reflect project needs; up to 5 years; no cost sharing required
Summary: Supports natural history research on disorders that currently benefit, or could benefit, from newborn screening.
Key Information: Studies must demonstrate how natural history data will improve clinical decisions or justify adding conditions to newborn screening panels.
This NIH R01 program is administered by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) through the Hunter Kelly Newborn Screening Research Program. It supports research on the natural history of conditions already included, or potentially suitable for inclusion, in statewide newborn screening programs. Clinical trials are optional.
Research may characterize symptom timing, genotype–phenotype relationships, and genetic, epigenetic, or environmental modifiers of disease progression. Goals include understanding biological mechanisms and clinical heterogeneity, improving diagnosis, supporting clinical trials and symptom management, providing predictive information to families and physicians, and establishing longitudinal data systems or patient registries. Projects may study multiple conditions if the need for natural history data is demonstrated for each, and may involve multi-state consortia of screening programs.